“Without this device, I would have found myself in a critical situation. » For Vincent Daffourd, who has suffered for more than ten years from idiopathic pulmonary fibrosis, there is no doubt that the connected bracelet he wears on his wrist saved his life. When in May 2020, his pulmonologist prescribed him the use of this new remote monitoring medical device, this tech enthusiast was nevertheless skeptical. “I thought it was a gimmick, but I had no alternative, all my medical appointments at the hospital had been canceled due to Covid, explains the forties. I quickly changed my mind regarding its usefulness. »
After four days of testing, the bracelet warns of dangerous and recurring desaturation during the night. Vincent Daffourd was then put on emergency oxygen therapy. Since then, the Montpellier resident has not hesitated to sing the praises of his connected device. Behind this medical innovation, exposed to the general public, like dozens of others, on the occasion of the MedInTechs fair, on Tuesday March 8 and Wednesday March 9, in Paris, is a young medtech from Rennes, Biosency, founded five years by Marie Pirotais and Yann Le Guillou.
Developed in collaboration with CEA-Leti, their connected bracelet continuously measures the oxygen saturation rate, heart rate and respiratory rate. The data is transmitted to the doctor, who can then immediately adapt the patient’s treatment in the event of an anomaly. A gain for the patient, who avoids hospitalization, but also for the Social Security budget. Nearly 600 patients in France have already benefited from this tricolor innovation.
“French innovation, American world leader”
Little known, French medtech, which brings together all the manufacturers of technologies and medical devices used to treat or improve the lives of patients (syringes, dressings, artificial organs, surgical robots, digital applications, etc.), has been gaining renewed attention since the health crisis. At the end of February, the government decided to devote an envelope of 400 million euros to it in order to bring out world champions.
Because if the tricolor medtech market, with nearly 31 billion euros in turnover in 2021, is today the largest on the continent following the German market, France is struggling to hatch giants on its soil. , despite promising nuggets. A few heavyweights, like BioMérieux in in vitro diagnostics, or Urgo in wound treatment, exist, but they remain rare.
You have 44.3% of this article left to read. The following is for subscribers only.
